Back
WDTC1HGNC Autosomal dominantPubMedNew gene

WDTC1 Haploinsufficiency as a Cause of Neurodevelopmental Phenotypes

Smith E, Faundes V, Zhao X et al.Clin Genet 2026 · June 2026
Relevance score
8/10
Disease / domain
Neurodevelopmental syndrome with intellectual disability, epilepsy, and variable obesity (WDTC1)
Source
PubMed
PMID 41793087
Share on LinkedIn

Variant / mechanism

WDTC1 haploinsufficiency, cullin-RING E3 ubiquitin ligase complex subunit, dysregulation of lipid storage and proteasome

Summary

7 individuals carrying heterozygous loss-of-function variants in WDTC1 are described with a neurodevelopmental syndrome featuring intellectual disability, seizures, and dysmorphic features. WDTC1 encodes a component of cullin-RING E3 ubiquitin ligase complexes involved in proteasomal degradation and lipid storage regulation. The cohort includes 6 newly reported cases (some de novo) and confirms a variable phenotypic spectrum with behavioral abnormalities and inconsistent obesity. This publication establishes WDTC1 as a new autosomal dominant NDD gene.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

WDTC1 enriches the group of NDD genes linked to the ubiquitin-proteasome pathway (UPS). The NDD + variable obesity association points to a specific diagnostic target and recalls other UPS genes (UBE3A, NEDD4L). A potential therapeutic axis via the mTOR/lipid pathway warrants literature monitoring.

Why this score?

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 2/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 8/10

Keywords

WDTC1neurodevelopmental disorderintellectual disabilityepilepsynew gene
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime